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There have been few functional imaging studies of negative symptoms in schizophrenia during the resting
state, particularly in Asian patients with schizophrenia. The aim of this study was to evaluate the
relationship between regional cerebral flood flow (rCBF) and negative symptoms, and to discuss the
association between severity and subgroups of negative symptoms and rCBF. Sixteen patients with chronic
schizophrenia were evaluated for negative symptoms using the Scale for the Assessment of Negative
Symptoms (SANS), and brain single photon emission computed tomography (SPECT) imaging to assess
rCBF during the resting state. Results were assessed using Spearman’s correlation analysis. Total SANS
scores were significantly negatively correlated with bilateral hypofrontality, especially in the left orbital
frontal and bilateral superior frontal areas. Subscores for attention were significantly negatively correlated
with the left lower frontal-temporal area and the right cerebellum. Subscores for anhedonia had a negative
correlation with the right hemisphere. Subscores for affect were negatively correlated with rCBF in the
bilateral prefrontal and bilateral superior frontal areas. There were no associations between rCBF and SANS
in alogia and avolition. These results support the notion that frontal lobe dysfunction in schizophrenia
is associated with negative symptoms. The left anterior hemisphere may play an important role in attention
deficit. These relationships between negative symptoms and neuroanatomy require further clarification.
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Functional image research regarding the difference in
regional cerebral blood flow (rCBF) between schizophrenics
and healthy people has been ongoing for more than two
decades. Hypofrontality has been found in 50% of resting-
state studies, but more often in activation paradigms [1].
There have been few studies regarding the association
between rCBF and negative symptoms on subscores in the
resting state, particularly in Asian patients with
schizophrenia, and the results are not consistent [2,3].
Interesting areas such as the frontal lobe [3–5] and the basal
ganglia [2] have been mentioned, and more severe negative
symptoms are usually found with more hypofrontality [2].
The aim of this study was to evaluate the relationship
between rCBF and negative symptoms in the resting state,
and to discuss the association between severity and
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subgroups of negative symptoms and rCBF in Chinese
patients.
MATERIALS AND METHODS
Subjects and clinical assessments
Patients with schizophrenia, based on DSM-III-R criteria,
were recruited to the study. Exclusion criteria were a history
of medical or neurologic diseases, tardive dyskinesia, a
history of alcohol or substance dependence, head injury,
electroconvulsive therapy, and the use of lithium treatment
during the months prior to assessment.
All patients’ clinical negative symptoms were assessed
using the Scale for the Assessment of Negative Symptoms
(SANS) 3 days before single photon emission computed
tomography (SPECT). SANS comprises five subscores:
affective flattening or blunting, alogia, avolition or apathy,
anhedonia or asociality, and lack of attention [6,7].
Brain SPECT imaging
Each subject underwent SPECT scans. A venous line was
inserted into the antecubital vein of the non-dominant arm
to inject tracer (925 MBq, 25 mCi, of technetium-99m
hexamethylpropylene amine oxime [99mTc-HMPAO]) 30
minutes before the study while patients kept their eyes
open in a quiet environment. The triple-headed rotating
gamma camera (MultiSPECT-3, Siemens, Hoffman Estates,
Illinois, USA) used for imaging had ultra high resolution
fan-beam collimators, which yield an image resolution of
approximately 8.5 mm full width half-maximum (FWHM).
SPECT data were acquired in a circular 360° rotation, with
120 steps of 30 seconds per step, in a 128 × 128 × 16 matrix.
The data were then processed by filtered back projection
with Butterworth and Ramp filters to reconstruct the
transverse images. Reconstructed transverse images were
aligned parallel to the canthomeatal (CM) line. The slice
thickness of each transverse image was 2.89 mm.
Semi-quantitative analysis of brain SPECT images
A total of six transverse images, at 10 pixels, 14 pixels, 18
pixels, 22 pixels, 26 pixels, and 30 pixels above the CM line,
were selected for analysis of the cortical regions of interest
(ROIs) using a reference system method [8].
Cortical ROIs were defined automatically. The outer
cortical border was demarcated by a threshold value, 50%
of the maximal counts of the section. The inner cortical
border was 8 pixels (23.18 mm) radically inward from the
outer cortical border. The angular areas on each transverse
image were divided equally into 30° sectors starting at the
12 o’clock position. As a result, there were 12 cortical ROIs
on each transverse image. These ROIs were labeled clockwise
and corresponded approximately to the anatomic regions
of the brain. For example, cortical ROI S1•2 (section 1, sector
2) and cortical ROI S3•7 (section 3, sector 7) represent the left
frontal and right occipital areas, respectively (Figure). ROIs
at the thalamic, basal ganglion, and occipital levels were
drawn manually by a senior nuclear medicine specialist.
The mean count density of ROIs (representing the degree of
tracer uptake in the region) was a marker of relative rCBF.
In this study, rCBF in each ROI was normalized using the
occipital region as the reference (ratio between one ROI and
the mean for the occipital region) because the primary
visual area was not hypothesized to be involved in negative
symptoms and was included as a control region.
Figure. Individual cortical regions of interest (ROIs) created by
subdividing the cortical annulus into equal angular sectors (30°)
approximately corresponding to the brain lobar structures as shown. For
example, brain section 1 (S1) is cut at 10 pixels above the canthomeatal
(CM) line. Sector 6 of brain section 1 (S1•6) is the left cerebellum. Brain
section 3 (S3) is cut at 18 pixels above the CM line. Sector 7 of brain
section 3 (S3•7) is the right occipital lobe. 1 pixel = 2.9 mm.
Right Left
Right hemisphere
S5: CM + 26 pixels
S3: CM + 18
pixels
S1: CM + 10
pixels
Left hemisphere
S5: CM + 26 pixels
S3: CM + 18 pixels
S1: CM + 10 pixels
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Statistical analysis
Spearman’s correlation analysis of non-parametric tests was
used to assess the relationship between SANS subgroup
scores and ROI. Since advanced age is reported to be associated
with declining rCBF [9,10], the age effect was controlled for in
the correlation analysis between rCBF and SANS scores. The
Mann-Whitney test was used for continuous variables.
Statistical calculations were carried out using SPSS/PC+V3.1
(SPSS Inc., Chicago, IL, USA). A p value less than 0.05 was
considered a statistically significant correlation.
RESULTS
Of 16 patients, nine were men and seven were women.
Their mean age was 33.29 ± 6.38 years (range, 25–50 years),
the mean duration of illness was 10.35 ± 5.33 years, and the
mean time in education was 12.44 ± 3.31 years. The mean
dose of antipsychotic was equivalent to 407 ±  207 mg
chlorpromazine; dosages were kept consistent during
examination to avoid any latent interference in the study.
Detailed data are shown in Table 1.
During the resting state, there was no association
between rCBF and age, education level, age at onset of
illness, duration of illness, or chlorpromazine-equivalent
dose. There was no statistical difference in SANS scores by
gender. After controlling for age effects, the total SANS
score was significantly correlated with rCBF in the bilateral
frontal region, especially in the left orbital frontal (S2•1,
r = –0.54; S2•2, r = –0.57) and bilateral superior frontal areas
(S5•12, r = –0.59; S5•2, r = –0.50; S6•11, r = –0.54; S6•1, r =
–0.58; S6•2, r = –0.51) (Table 2). The severity of negative
symptoms was associated with a decrease in bilateral frontal
cerebral blood flow in patients with schizophrenia.
SANS attention subscores were significantly negatively
correlated with rCBF in the left lower frontal-temporal area
(S1•1, r = –0.54; S1•2, r = –0.59; S1•3, r = –0.56; S1•4, r = –0.67)
and the right cerebellum (S1•8, r = –0.53) (Table 2). Anhedonia
scores were significantly negatively correlated with rCBF in
the right hemisphere, dispersed over the frontal (S5•12, r =
–0.53), temporal (S2•10, r = –0.50), parietal (S6•8, r = –0.56),
and occipital areas (S5•7, r = –0.69). In addition, affect
subscores were significantly negatively correlated with rCBF
in the bilateral prefrontal areas (S2•1, r = –0.52; S3•12, r =
–0.50; S4•1, r = –0.55) and bilateral superior frontal areas
(S5•1, r = –0.51; S5•2, r = –0.63; S5•12, r = –0.58; S6•1, r =
–0.59; S6•2, r = –0.60; S6•11, r = –0.54). There were no
associations between rCBF and SANS alogia and avolition
subscores.
DISCUSSION
Decreased frontal rCBF is associated with negative
symptoms and more prominent negative symptoms are
related to greater decreases in frontal rCBF [2]. However,
inconsistent rCBF findings of frontal activities in
schizophrenia during the resting state have been reported
Table 1. Demographic data of 16 patients with schizophrenia
Age (yrs ) Sex Illness duration (yr) Education (yr) Medication* (mg)
35 M 17 12 600
35 M 8 9 400
35 F 10 12 100
34 M 16 12 367
32 M 7 12 400
40 F 13 12 365
28 F 10 12 1,060
34 F 16 12 390
30 M 8 14 400
22 F 4 12 1,000
25 M 6 12 610
35 M 9 16 250
36 M 10 9 164
46 F 23 6 250
26 F 4 12 360
44 M 12 22 160
*Chlorpromazine-equivalent dose.
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since 1948 [3]. Liddle et al showed hypofrontality in patients
with schizophrenia in a large cross-sectional study of 30
chronic schizophrenics [4]. Suzuki et al demonstrated that
the negative symptoms in 39 schizophrenics were related to
left frontal lobe dysfunction during the resting period [5].
Yuasa et al’s studies of 26 medicated schizophrenia patients
suggested psychomotor poverty correlated with decreased
rCBF in the bilateral superior frontal areas, and increased
rCBF in the left thalamus and right basal ganglia [11]. These
studies revealed that the severity of negative symptoms was
associated with hypofrontality. Our findings also support a
decline in rCBF in the frontal areas during the resting state in
schizophrenics with more negative symptoms.
Zemishlany et al investigated nine unmedicated
schizophrenia patients at rest and during the continuous
performance test (CPT) [12]. They found no association
between rCBF and severity of negative symptoms during
the resting state, but the severity of negative symptoms was
associated with lower frontal activation during CPT and
with higher posterior activation. This conclusion was
supported by Erkwoh et al’s studies of 24 never-treated
actively psychotic schizophrenic patients [13], which showed
that negative symptoms have no linkage to hypofrontality,
either before or after treatment. These inconsistencies might
be due to several reasons. First, small samples of patients
mean that factors such as chronicity, severity of negative
symptoms, level of functioning, and drug type and dosage
vary across studies. Second, the definition of the resting
state (eyes open or closed, covered or uncovered), other
sensory status, and whether studies were controlled or
not affect the reproducibility of the study [2]. Third, the
different regional parameters (region to whole brain,
anterior to posterior, occipital area or cerebellum) and
absolute values of activity in rCBF might have influenced
results.
In the current study, rCBF correlated with the subscores
of attention, anhedonia, and affect. Zemishlany et al also
showed a negative correlation between attention and left
hyperfrontality [12]. The lower left frontal-temporal base
and the right cerebellum had a dominance of flow change in
attention subscore in this study. The left anterior hemisphere
appears to play an important role in attention, which is
similar to this and other studies [12,14]; however, the role of
the right hemisphere is still not clear. Zemishlany et al
found that the anhedonia subscale was negatively associated
with rCBF in the left frontal and posterior regions during
the activating condition [12]. In Sagawa et al’s study, inferior
frontality was associated with negative symptoms such as
anhedonia on the Wisconsin Card Sorting Test [14]. It is still
unclear whether poor attention or anhedonia, or even
Table 2. Correlation between regional cerebral blood flow (rCBF) and Scale for the Assessment of Negative Symptoms (SANS)
scores
Brain region Imaging slice* Affect† Anhedonia† Attention† Total score†
Right cerebellum S1 • 8 0.36 0.21 –0.53
‡ 0.10
Left frontal (orbital frontal) S1 • 1 0.16 –0.05 –0.54
‡ –0.14
S1 • 2 0.18 0.10 –0.59
‡ –0.05
Left temporal (middle inferior) S1 • 3 0.30 0.40 –0.56
‡ 0.16
S1 • 4 0.39 0.45 –0.67
§ 0.13
Right superior–middle temporal S2 • 10 –0.37 –0.50
‡ 0.14 –0.38
Left frontal (prefrontal) S2 • 1 –0.52
‡ –0.49 –0.29 –0.54‡
S2 • 2 –0.47 –0.41 –0.37 –0.57
‡
Right frontal (prefrontal) S3 • 12 –0.50
‡ –0.46 –0.13 –0.47
Left frontal (prefrontal) S4 • 1 –0.55
‡ –0.38 –0.07 –0.45
Right frontal (prefrontal) S5 • 12 –0.58
‡ –0.53‡ –0.20 –0.59‡
Right occipital S5 • 7 –0.35 –0.69
§ 0.18 –0.40
Left frontal (prefrontal) S5 • 1 –0.51
‡ –0.44 –0.17 –0.48
Left frontal (frontal eye field to premotor) S5 • 2 –0.63
‡ –0.45 –0.05 –0.50‡
Right frontal (supplementary–premotor) S6 • 11 –0.54
‡ –0.43 –0.28 –0.54‡
Right parietal S6 • 8 –0.50 –0.56
‡ 0.02 –0.43
Left frontal (prefrontal) S6 • 1 –0.59
‡ –0.49 –0.22 –0.58‡
Left frontal (supplementary–premotor) S6 • 2 –0.60
‡ –0.42 –0.18 –0.51‡
*See Figure; †after controlling for age effects; ‡p < 0.05; §p < 0.01.
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flattened affect, are associated with hypofrontality. Our
study showed right hemisphere dominance of flow change
in anhedonia. Hypofrontality appeared to be related to
anhedonia; however, the involvement of other cerebral
regions is controversial. Flattened affect was associated
with bilateral frontal change, which is partially compatible
with Sabri et al’s study in which affective flattening had a
negative correlation to frontal, temporal, basal ganglia, and
thalamic rCBF ratios on the left side [15]. In the current
study, there were no associations between rCBF and SANS
in alogia and avolition. These symptoms, which are related
to neuroanatomy, require further clarification.
Our results need to be interpreted with caution
because of the following limitations. First, medication
will influence rCBF [16]. In spite of the non-significance
of the correlation between rCBF and neuroleptic dose in
the current study, a study with drug-free samples is
needed. Second, this study only included a small sample
of patients. Third, using the atlas-overlap technique in
SPECT imaging to measure rCBF is less accurate than
using magnetic resonance imaging co-registration in
positron emission tomography.
These results support the positive correlation between
frontal lobe dysfunction in rCBF and negative symptoms in
patients with schizophrenia. The left anterior hemisphere
may play an important role in attention deficit. These
negative symptoms, related to neuroanatomy, need further
investigation.
CONCLUSIONS
Our study supports the hypothesis that frontal lobe
dysfunction in schizophrenia is associated with negative
symptoms, especially attention, anhedonia, and affect. The
left anterior hemisphere plays an important role in attention
deficit. The relationships between these negative symptoms
and neuroanatomy need further clarification.
ACKNOWLEDGMENTS
The authors wish to thank Dr. Yu-Hsuan Chou, Dr. Chew-
Cheng Chen, Miss Ching-Lin Chu, and Miss Chin-Yin
Hsaio for their statistical, administrative, and editorial
assistance in the preparation of this manuscript.
REFERENCES
1. Grasby PM. Functional positron emission tomography in
psychiatry. In: Gelder MG, Lopez-Ibor JJ, Andreasen NC, eds.
New Oxford Textbook of Psychiatry. New York: Oxford University
Press, 2000;204–11.
2. Raquel E, Ruben C. Schizophrenia: brain structure and function.
In: Kaplan HI, Sadock BJ, eds. Comprehensive Textbook of
Psychiatry, 7th ed. Philadelphia: Lippincott Williams & Wilkins,
2000:1122–5.
3. Andreasen NC, Rezai K, Alliger R, et al. Hypofrontality in
neuroleptic-naive patients and in patients with chronic
schizophrenia. Assessment with xenon 133 single-photon
emission computed tomography and the Tower of London.
Arch Gen Psychiatry 1992;49:943–58.
4. Liddle PF, Friston KJ, Frith CD, et al. Patterns of cerebral blood
flow in schizophrenia. Br J Psychiatry 1992;160:179–86.
5. Suzuki M, Kurachi M, Kawasaki Y, et al. Left hypofrontality
correlates with blunted affect in schizophrenia. Jpn J Psychiatry
Neurol 1992;46:653–7.
6. Andreasen NC, Arndt S, Miller D, et al. Correlational studies
of the Scale for the Assessment of Negative Symptoms and the
Scale for the Assessment of Positive Symptoms: an overview
and update. Psychopathology 1995;28:7–17.
7. Yang YK, Yeh TL, Lai TJ, et al. Negative symptoms in schizophrenic
inpatients. Chin Psychiatry (Taiwan) 1995;9:45–52.
8. Mountz JM, Wilson MW, Wolff CG, et al. Validation of a
reference method for correlation of anatomic and functional
brain images. Comput Med Imaging Graph 1994;18:163–74.
9. Pantano P, Baron JC, Lebrun-Grandie P, et al. Regional cerebral
blood flow and oxygen consumption in human aging. Stroke
1984;15:635–41.
10. Shirahata N, Henriksen L, Vorstrup S, et al. Regional cerebral blood
flow assessed by 133Xe inhalation and emission tomography: normal
values. J Comput Assist Tomogr 1985;9:861–6.
11. Yuasa S, Kurachi M, Suzuki M, et al. Clinical symptoms and
regional cerebral blood flow in schizophrenia. Eur Arch
Psychiatry Clin Neurosci 1995;246:7–12.
12. Zemishlany Z, Alexander GE, Prohovnik I, et al. Cortical
blood flow and negative symptoms in schizophrenia.
Neuropsychobiology 1996;33:127–31.
13. Erkwoh R, Sabri O, Steinmeyer EM, et al. Psychopathological
and SPECT findings in never-treated schizophrenia. Acta
Psychiatr Scand 1997;96:51–7.
14. Sagawa K, Kawakatsu S, Komatani A, Totsuka S. Frontality,
laterality, and cortical-subcortical gradient of cerebral blood flow in
schizophrenia: relationship to symptoms and neuropsycho-
logical functions. Neuropsychobiology 1990–91;24:1–7.
15. Sabri O, Erkwoh R, Schreckenberger M, et al. Regional cerebral
blood flow and negative/positive symptoms in 24 drug-naive
schizophrenics. J Nucl Med 1997;38:181–8.
16. Lee SM, Yip PK, Jeng JS, et al. Spontaneous oscillations of cerebral
blood flow velocity in the middle cerebral arteries of normal
subjects and schizophrenic patients. Psychiatry Res 1999;92:93–102.
